4Ts Score System for Heparin-Induced Thrombocytopenia

4Ts Score System for Heparin-Induced Thrombocytopenia

4Ts Score System assessment for Heparin-Induced Thrombocytopenia is an alternative evaluation tool prior to time-consuming antibody testing for HIT or empiric substitution of heparin for another anti-coagulant.

Thrombocytopenia:
Platelet count fall 30–50% OR platelet nadir 10–19×109/l
Platelet count fall <30% OR platelet nadir <10×109/l

Timing of platelet count fall:
Clear onset between days 5–10 OR platelet fall ≤1 day (prior heparin exposure within 30 days)
Consistent with days 5–10 fall, but not clear; onset after day 10 OR fall ≤1 day (prior heparin exposure 30–100 days ago)
Platelet count fall <4 days without recent exposure

Thrombosis or other sequelae:
New thrombosis OR skin necrosis; acute systemic reaction post-IV heparin bolus
Progressive OR recurrent thrombosis; non-necrotizing skin lesions; suspected thrombosis (not proven)
None

Other causes for thrombocytopenia:
None apparent
Possible
Definite



Patient’s score Range Risk stratification Probability of HIT Recommendation
0 0 0 0 0

Consider using the 4Ts scoring system 4Ts Score for Heparin-Induced Thrombocytopenia for:

  • Differential diagnostic HIT and other causes of thrombocytopenia;
  • Patients’ risk stratification for HIT in patients with thrombocytopenia who are currently or were recently on heparin derived agents.
ThrombocytopeniaPlatelet count fall >50% AND platelet nadir ≥20×109/l+2
 Platelet count fall 30–50% OR platelet nadir 10–19×109/l+1
 Platelet count fall <30% OR platelet nadir <10×109/l0
Timing of platelet count fallClear onset between days 5–10 OR platelet fall ≤1 day (prior heparin exposure within 30 days)+2
 Consistent with days 5–10 fall, but not clear; onset after day 10 OR fall ≤1 day (prior heparin exposure 30–100 days ago)+1
 Platelet count fall <4 days without recent exposure0
Thrombosis or other sequelaeNew thrombosis OR skin necrosis; acute systemic reaction post-IV heparin bolus+2
 Progressive OR recurrent thrombosis; non-necrotizing skin lesions; suspected thrombosis (not proven)+1
 None0
Other causes for thrombocytopeniaNone apparent+2
 Possible+1
 Definite0

Results evaluation:

4Ts Score System for Heparin-Induced Thrombocytopenia consisted of four criteria, each of which was worth 0, 1, or 2 points. To carry out stratification on the scale, it is necessary to summarize the obtained points.

ScoreRisk stratificationProbability of HIT
≤3 pointslow probability for HIT≤5% in original study, <1% in meta-analysis
4-5 pointsintermediate probability for HIT~14%
6-8 pointshigh probability for HIT~64%

Patients from the low-risk category frequently do not need further testing for HIT based on the assessment with 4Ts Score for Heparin-Induced Thrombocytopenia. Patients from the intermediate or high-risk groups require further laboratory evaluation for HIT or switching to a non-heparin-derived anti-coagulant.

Detailed parameters evaluation:

Category2 points1 point0 points
ThrombocytopeniaPlatelet count fall > 50% AND platelet nadir ≥ 20 ×109/lPlatelet count fall 30%–50% OR platelet nadir 10–19 ×109/lPlatelet count fall < 30% OR platelet nadir < 10 ×109/l
Timing of platelet count fallClear onset between days 5 and 10 OR platelet fall ≤ 1 day (prior heparin exposure within 30 days)Consistent with days 5–10 fall, but not clear (e.g. missing platelet counts) OR onset after day 10 OR fall ≤ 1 day (prior heparin exposure 30–100 days ago)Platelet count fall < 4 days without recent heparin exposure
Thrombosis or other sequelaeNew thrombosis (confirmed) OR skin necrosis at heparin injection sites OR acute systemic reaction after intravenous heparin bolusProgressive or recurrent thrombosis OR nonnecrotizing (erythematous) skin lesions OR suspected thrombosis (not proven)None
Other causes for thrombocytopeniaNone apparentPossibleDefinite

Gold standard for diagnosis of HIT was either:

  • A platelet serotonin release assay (SRA) and a PF4/polyanion-enzyme immunoassay (EIA) with ≥ 50% serotonin release and positive EIA, OR
  • A positive heparin-induced platelet activation (HIPA) test in at least three of four donor platelets.

4Ts Score for Heparin-Induced Thrombocytopenia was developed based on the prospective studies in patients being evaluated for thrombocytopenia or suspected HIT in two clinical settings: inpatients at Hamilton General Hospital in Canada and various clinicians in a variety of healthcare settings in Germany and Austria. A subsequent review and meta-analysis of the 4Ts scoring system for HIT revealed that patients in the low-risk group had a negative predictive value of 0.998, irrespective of type of clinician, prevalence of HIT, or patient population. However, one of the four components of their scoring system, other causes for thrombocytopenia, is subjective.

Literature:
Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 Ts) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759–65. https://pubmed.ncbi.nlm.nih.gov/16634744/
Vatanparast R, Lantz S, Ward K, Crilley PA, Styler M. Evaluation of a pretest scoring system (4Ts) for the diagnosis of heparin-induced thrombocytopenia in a university hospital setting. Postgrad Med. 2012 Nov;124(6):36-42. https://pubmed.ncbi.nlm.nih.gov/23322137/

Register on our website right now to have access to more learning materials!

Charlson Comorbidity Index (CCI) Online Calculator

Charlson Comorbidity Index predicts 10-year survival in patients with multiple comorbidities.

Loading...

History of definite or probable MI (EKG changes and/or enzyme changes)

Exertional or paroxysmal nocturnal dyspnea and has responded to digitalis, diuretics, or afterload reducing agents

Intermittent claudication or past bypass for chronic arterial insufficiency, history of gangrene or acute arterial insufficiency, or untreated thoracic or abdominal aneurysm (≥6 cm)

History of a cerebrovascular accident with minor or no residua and transient ischemic attacks

Chronic cognitive deficit

Any history of treatment for ulcer disease or history of ulcer bleeding

Severe = cirrhosis and portal hypertension with variceal bleeding history, moderate = cirrhosis and portal hypertension but no variceal bleeding history, mild = chronic hepatitis (or cirrhosis without portal hypertension)

Severe = on dialysis, status post kidney transplant, uremia, moderate = creatinine >3 mg/dL (0.27 mmol/L)


* Required
VariablePointsAge <50…
Read More

Multiple Myeloma Diagnostic Criteria – Online Calculator

Loading...

≥1 of the following (A or B)

≥1 myeloma defining event (C1 or C2)


* Required
For Multiple Myeloma Diagnostic Criteria assessment necessary to provide selection of the…
Read More

SAVED VTE Score

SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Read More

IMPEDE VTE Score

IMPEDE score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Read More
Share:

Related Articles

Register and get a gift!

User registration







  • Use only Latin letters and numbers.













  • Strength indicator

    Password at least 12 characters, uppercase and lowercase letters, numbers and symbols like! "? $ ^ &